Company data sheet · Forward Pharma A/S
Forward Pharma A/S: four lost years, and the economy wasn't the reason.
- Industry
- Pharmaceutical Preparations Manufacturing
- Headquarters
- Denmark
- Sources
- SEC filings (2014–2023), Stratrix's verified Decision Cases, market data and official economic statistics for Denmark
- Data as of
- November 1, 2026
- From profit to four straight losses. Forward Pharma A/S earned $0.9 billion in 2017–2017. Then it lost money every year from 2018 to 2021: $0 billion in all.
- It wasn't the cycle. The losses began in 2018, a year Denmark economy grew 1.9% and factories added jobs. When a company falls while its economy grows, look inside the company first.
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2017 | $1.3 billion | $0.9 billion |
As reported in its annual filings. Losses in red.
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Economic context: 6 measures for Denmark, every year since 2016, from the official sources.
- Peer comparison: against 953 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.